PFE: PFIZER INC Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 59 hrs, 1 min

Symbol	Value	Change	Percentage Change
DJIA	11,288.54	73.03	0.65%
NASDAQ	2,245.38	-6.08	-0.27%
S&P 500	1,262.90	1.38	0.11%

PFIZER INC

PFE

Stock price

17.75 0.13 0.74%

as of 01:01 PM EDT on 07/03/2008 in USD (NYSE Delay: 20 mins.)
Extended Hours

— — —

Analyst Consensus

Hold
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: PFE

PFIZER INC Profile

Pfizer pfabricates pfarmaceuticals pfor quite a pfew inpfirmities. The company is the world's largest research-based pharmaceuticals firm. Its best-known products include erectile dysfunction therapy Viagra, pain management drug Celebrex, antidepressant Zoloft, and cholesterol-lowering Lipitor. Pfizer also keeps Fluffy and Fido in mind with its animal health products, including Revolution (antiparasitic). The company markets its pharmaceuticals directly to health care providers and patients; most of its sales are conducted through wholesalers including McKesson and Cardinal Health. Pfizer has sold its consumer unit -- which made such sniffle-and-sneeze treatments as Benadryl and Sudafed -- to Johnson & Johnson.

Jeffrey B. Kindler: CEO

235 E. 42nd St.

New York, NY 10017-5755

http://www.pfizer.com

Phone: 212-573-2323

Fax: —

Sector: Healthcare Industry: Drugs

2007 Sales	2007 Sales Growth	2007 Net Income	2007 Employees
$48,418,000,000	0.1%	$8,144,000,000	86,600

Key Executives: PFE

Name	Title	Officer Since
Jeffrey B. Kindler	CEO	7/31/06
Frank A. D'Amelio	CFO	-
Dr. Joseph M. Feczko	Chief Medical Officer	-
Allen P. Waxman	General Counsel	-
Ian C. Read	Senior VP	-
Martin Mackay	Senior VP	-
Dr. Corey S. Goodman, Ph.D.	Senior VP	-
Sally Susman	Senior VP	-

View All Key Executives

— View Full Profile

Alan G. Levin

Dr. Dennis A. Ausiello, M.D., The Jackson Professor of Clinical Medicine at Harvard Medical School and Chief of Medicine at Massachusetts General Hospital since 1996. President of the Association of American Physicians in 2006. Member of the Institute of Medicine of the National Academy of Sciences and a Fellow of the American Academy of Arts and Sciences. Director of MicroCHIPS (drug delivery technology) and Advisor to the Chairman of the Board... View Full Profile

Dr. Dennis A. Ausiello, M.D.

Allen P. Waxman, Senior Vice President and General Counsel, since August 2006. Mr. Waxman joined Pfizer in 2003 as Senior Assistant General Counsel and Chief of Litigation. He was promoted to Associate General Counsel in 2005 and to General Counsel in 2006. Prior to joining Pfizer, Mr. Waxman was a partner at the law firm of Williams & Connolly, LLP in Washington D.C., since 1995, and during that same period was an adjunct professor of law at... View Full Profile

Allen P. Waxman

Joseph M. Feczko, Senior Vice President and Chief Medical Officer, since August 2006. Dr. Feczko has held various positions of increasing responsibility in research and development and medical and regulatory operations. After four years as Medical Director at Glaxo's Research & Development headquarters in London, Dr. Feczko returned to Pfizer in 1996 and was promoted to the position of Senior Vice President, Medical and Regulatory Operations for... View Full Profile

Dr. Joseph M. Feczko

Ian C. Read, Our Senior Vice President and President, Worldwide Pharmaceutical Operations since August 2006. Mr. Read has held various positions of increasing responsibility in pharmaceutical operations. He previously served as Area President, Europe, Canada, Africa and Middle East, Senior Vice President of the Pfizer Pharmaceuticals Group, and Executive Vice President of Europe and Canada. In July 2002 he was appointed President -Europe and... View Full Profile

Ian C. Read

Richard H. Bagger, Senior Vice President, Worldwide Public Affairs and Policy, since August 2006. Since joining Pfizer in 1993, Mr. Bagger has held various positions of increasing responsibility in Pfizer's Corporate Affairs Division. He was promoted to Vice President, Government Relations in 2002 and to Senior Vice President, Government Relations in 2003. He assumed additional responsibility for Public Affairs and Policy in 2005. Prior to... View Full Profile

Richard H. Bagger

Constance J. Horner, Guest Scholar from 1993 until 2005 at The Brookings Institution, an organization devoted to nonpartisan research, education and publication in economics, government, foreign policy and the social sciences. Commissioner of the U.S. Commission on Civil Rights from 1993 to 1998. Served at the White House as Assistant to President George H. W. Bush and as Director of Presidential Personnel from August 1991 to January 1993. Deputy... View Full Profile

Constance J. Horner

William R. Howell, Chairman Emeritus of J. C. Penney Company Inc., a major retailer, since 1997. Chairman of the Board and Chief Executive Officer of J. C. Penney Company from 1983 to 1997. Director of American Electric Power Company, Exxon Mobil Corporation, Halliburton Company and The Williams Companies, Inc. Mr. Howell will not be standing for re-election at American Electric Power Company, Exxon Mobil Corporation and Halliburton Company in... View Full Profile

William R. Howell

Frank A. D'Amelio, Our Chief Financial Officer since September 2007. Previously, he was Senior Executive Vice President of Integration and Chief Administrative Officer of Alcatel-Lucent from November 2006 until August 2007. Mr. D'Amelio was the Chief Operating Officer of Lucent Technologies from January 2006 until November 2006. From May 2001 until January 2006, he was Executive Vice President, Administration and Chief Financial Officer of Lucent... View Full Profile

Frank A. D'Amelio

Jeffrey B. Kindler, Our Chairman since December 19, 2006. Our Chief Executive Officer since July 31, 2006. Vice Chairman and General Counsel from March 2005 to July 30, 2006. Executive Vice President and General Counsel from April 2004 to March 2005, and Senior Vice President and General Counsel from January 2002 to April 2004. Prior to joining Pfizer, Mr. Kindler served as Chairman of Boston Market Corporation from 2000 to 2001, and President of... View Full Profile

Jeffrey B. Kindler

Jeffrey B. Kindler, Our Chairman since December 19, 2006. Our Chief Executive Officer since July 31, 2006. Vice Chairman and General Counsel from March 2005 to July 30, 2006. Executive Vice President and General Counsel from April 2004 to March 2005, and Senior Vice President and General Counsel from January 2002 to April 2004. Prior to joining Pfizer, Mr. Kindler served as Chairman of Boston Market Corporation from 2000 to 2001, and President of... View Full Profile

Loretta V. Cangialosi

Jeffrey B. Kindler, Our Chairman since December 19, 2006. Our Chief Executive Officer since July 31, 2006. Vice Chairman and General Counsel from March 2005 to July 30, 2006. Executive Vice President and General Counsel from April 2004 to March 2005, and Senior Vice President and General Counsel from January 2002 to April 2004. Prior to joining Pfizer, Mr. Kindler served as Chairman of Boston Market Corporation from 2000 to 2001, and President of... View Full Profile

Margaret M. Foran

Dr. Michael S. Brown, Distinguished Chair in Biomedical Sciences from 1989 and Regental Professor from 1985 at the University of Texas Southwestern Medical Center at Dallas. Co-recipient of the Nobel Prize in Physiology or Medicine in 1985 and the National Medal of Science in 1988. Member of the National Academy of Sciences, the Institute of Medicine and Foreign Member of the Royal Society (London). Director of Regeneron Pharmaceuticals, Inc. Our... View Full Profile

Dr. Michael S. Brown

Robert N. Burt, Retired Chairman and Chief Executive Officer of FMC Corporation, a company that manufactures chemicals, and FMC Technologies Inc., a company that manufactures machinery. Mr. Burt was Chairman of the Board of FMC Corporation from 1991 to December 2001, its Chief Executive Officer from 1991 to August 2001 and a member of its Board of Directors from 1989 to April 2002. Chairman of the Board of FMC Technologies, Inc. from June 2001 to... View Full Profile

Robert N. Burt

Robert N. Burt, Retired Chairman and Chief Executive Officer of FMC Corporation, a company that manufactures chemicals, and FMC Technologies Inc., a company that manufactures machinery. Mr. Burt was Chairman of the Board of FMC Corporation from 1991 to December 2001, its Chief Executive Officer from 1991 to August 2001 and a member of its Board of Directors from 1989 to April 2002. Chairman of the Board of FMC Technologies, Inc. from June 2001 to... View Full Profile

David L. Shedlarz

Dr. Dana G. Mead, Chairman of Massachusetts Institute of Technology Corporation since July 1, 2003. Chairman and Chief Executive Officer of Tenneco, Inc. from 1994 until his retirement in 1999. Chairman of two of the successor companies of the Tenneco conglomerate, Tenneco Automotive Inc. and Pactiv Corporation, global manufacturing companies with operations in automotive parts and packaging, from November 1999 to March 2000. Chairman of the... View Full Profile

Dr. Dana G. Mead

Dr. Dana G. Mead, Chairman of Massachusetts Institute of Technology Corporation since July 1, 2003. Chairman and Chief Executive Officer of Tenneco, Inc. from 1994 until his retirement in 1999. Chairman of two of the successor companies of the Tenneco conglomerate, Tenneco Automotive Inc. and Pactiv Corporation, global manufacturing companies with operations in automotive parts and packaging, from November 1999 to March 2000. Chairman of the... View Full Profile

John L. LaMattina

W. Don Cornwell, Chairman of the Board and Chief Executive Officer since 1988 of Granite Broadcasting Corporation, a group broadcasting company. On December 11, 2006, Granite Broadcasting Corporation filed for voluntary reorganization under Chapter 11 of the U.S. Bankruptcy Code, and emerged from its restructuring on June 4, 2007. Director of Avon Products, Inc. Director of the Wallace Foundation. Trustee of Big Brothers/Sisters of New York. Our... View Full Profile

W. Don Cornwell

George A. Lorch, Chairman Emeritus of Armstrong Holdings, Inc., a global company that manufactures flooring and ceiling materials, since August 2000. Chairman and Chief Executive Officer of Armstrong Holdings, Inc. from May 2000 to August 2000. Chairman of Armstrong World Industries, Inc. from May 1994 to May 2000, its President and Chief Executive Officer from September 1993 to May 2000, and a Director from 1988 to November 2000. Director of... View Full Profile

George A. Lorch

M. Anthony Burns, Chairman Emeritus since May 2002, Chairman of the Board from May 1985 to May 2002, Chief Executive Officer from January 1983 to November 2000, and President from December 1979 to June 1999 of Ryder System, Inc., a provider of transportation and logistics services. Director of The Black & Decker Corporation and J.C. Penney Company, Inc. Life Trustee of the University of Miami. Our Director since 1988.... View Full Profile

M. Anthony Burns

William H. Gray, III, Chairman of the Amani Group, a government affairs firm, since August 2004. Pastor Emeritus of the Bright Hope Baptist Church in Philadelphia since June 2005. President and Chief Executive Officer of The College Fund/UNCF (Educational Assistance) from September 1991 to June 2004. Mr. Gray served as a Congressman from the Second District of Pennsylvania from 1979 to 1991, and at various times during his tenure, served as... View Full Profile

William H. Gray, III

William C. Steere, Jr., Chairman Emeritus of Pfizer Inc. since July 2001. Chairman of our Board from 1992 to April 2001 and our Chief Executive Officer from February 1991 to December 2000. Director of MetLife, Inc. and Health Management Associates, Inc. Director of the New York University Medical Center and the New York Botanical Garden. Member of the Board of Overseers of Memorial Sloan-Kettering Cancer Center. Our Director since 1987.... View Full Profile

William C. Steere, Jr.

On September 27, 2007, Pfizer Inc. announced the election of Suzanne Nora Johnson to the Pfizer Board of Directors effective September 27, 2007. Retired Vice Chairman, Goldman Sachs Group, Inc., since January 2007. During her 21 year tenure with Goldman Sachs, Ms. Nora Johnson served in various leadership roles, including Head of the firm's Global Healthcare Business, Head of Global Research and Chair of the Global Markets Institute. Director of... View Full Profile

Suzanne Nora Johnson

Martin Mackay, Our Senior Vice President; President of Pfizer Global Research & Development (PGRD) since October 2007. Early in 2007, he was named Vice President PGRD, Head of Worldwide Development. From 2003 to 2007, he held the position of Senior Vice President, Head of Worldwide Research and Technology. From 1999 to 2003 he was the Senior Vice President, Head of Worldwide Discovery. In 1998 he held the position of Vice President, UK Discovery... View Full Profile

Martin Mackay

On September 27, 2007, Pfizer Inc. announced the election of James M. Kilts to the Pfizer Board of Directors effective September 27, 2007. Founding Partner, Centerview Partners Management, LLC, a financial advisory firm, since 2006. Vice Chairman, The Procter & Gamble Company, 2005-2006. Chairman and Chief Executive Officer, The Gillette Company, 2001-2005 and President, The Gillette Company, 2003-2005. President and Chief Executive Officer,... View Full Profile

James M. Kilts

Mary McLeod, Senior Vice President of Pfizer's Worldwide Human Resources, since April 2007. She served in this role on an interim basis from January to April 2007 while she was a consultant at Korn Consulting Group. Prior to that, she led Human Resources for Symbol Technologies from 2005 to 2006 and was the head of Human Resources for Charles Schwab, from 2001 to 2004. From 1999 to 2001, she was Vice President-Human Resources for Cisco Systems... View Full Profile

Mary S. McLeod

Corey S. Goodman, Senior Vice President; President of Pfizer's Biotherapeutics and Bioinnovation Center, since October 2007. Dr. Goodman has advised numerous biotechnology companies and co-founded two companies, Exelixis and Renovis, Inc. He served as President and Chief Executive Officer of Renovis from 2001 until 2007. Dr. Goodman was a professor at the University of California, Berkeley from 1987 to 2001, and, while on faculty, served as the... View Full Profile

Dr. Corey S. Goodman, Ph.D.

Sally Susman, Senior Vice President - Chief Communications Officer since February 2008. Prior to joining Pfizer, Ms. Susman held senior level positions at The Estee Lauder Companies, including Executive Vice President from December 2004 to January 2008 and Senior Vice President - Global Communications from September 2000 through November 2004. Earlier in her career, Ms. Susman was responsible for all of American Express International's internal... View Full Profile

Sally Susman

Natale S. Ricciardi, Senior Vice President; President - Pfizer Global Manufacturing since October 2004. He held a number of positions of increasing responsibility in manufacturing before being named U.S. Area Vice President/Team Leader for Pfizer Global Manufacturing in 1999. Mr. Ricciardi joined us in 1972. He is a Director of Mediacom Communications Corp.... View Full Profile

Natale S. Ricciardi

Top Competitors: PFE

View Detailed Competitors Chart

Insider Trends: PFE
Sentiment for PFE is POSITIVE
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: PFE

Date	Name	Shares	Transaction Type	Market Value
06/30/08	SCHULMAN AMY W	100,000	Award of Stock Options	$0.00
05/21/08	CORNWELL W DON	500	Purchase	$10,000.00
05/07/08	NORA JOHNSON SUZANNE M	10,000	Purchase	$199,300.00

View All Insider Activity

Ownership Breakdown : PFE

Large Block Holder Type	Number
Institutions	1,990.00
Mutual Fund	3,805.00
Other Major	26.00

Full Details

Indices : PFE

Symbol	Name	Last Trade	Change
$RUI.X	Russell 1000 Index	690.92	-0.56 -0.08%
$INX	S&P 500 Index	1,262.90	1.38 0.11%
$OEX	S&P 100 Index	578.13	2.76 0.48%
$INDU	Dow Jones Industrial Average Index	11,288.54	73.03 0.65%
—	Fortune 500 Industrial Index	—	——%

View all Indices that include PFE

Short Interest Volume: PFE

Data as of 6/10/08

Current Short Interest Shares	1.10 B
Current Short Interest Ratio	1.00
Float	6.76 B

Short Interest as % of Float	0.90
Average Daily Volume	55.12 M
Outstanding Shares	6.77 B

Full Details

SEC Filings: PFE

Accepted Date	Description
07/01/2008	SEC Filing: Insider Buy/Sell
07/01/2008	SEC Filing: Insider Buy/Sell
07/01/2008	SEC Filing: Insider Buy/Sell

View all SEC Filings

Get Quote Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

PFIZER INC

PFE

Stock price

17.75 0.13 0.74%

as of 01:01 PM EDT on 07/03/2008 in USD (NYSE Delay: 20 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell

Live Updates:

Ticker

Dynamic view of the market

PFIZER INC

PFE

Stock price

Extended Hours

Analyst Consensus

PFIZER INC Profile

Key Executives: PFE

Top Competitors: PFE

Insider Trends: PFE

Insider Transactions: PFE

Ownership Breakdown : PFE

Indices : PFE

Short Interest Volume: PFE

SEC Filings: PFE

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials

Market Movers

Related Resources

PFIZER INC

PFE

Stock price

Analyst Consensus